Newsroom

16-11-2018

Accord Healthcare are proud supporters of IHP

Millions of people around the world are suffering because they have little or no access to medicine and health care. They live in communities made vulnerable by...

Read more

19-10-2018

Accord acts differently to plot a path towards further growth

James Burt, EVP EMENA and Paul Tredwell, VP Specialty Brands met with Aidan Fry from Generics Bulletin to talk about Accord’s continued rise across Europe in hospital and retail generics and...

Read more

10-10-2018

Accord Healthcare - the most recognised company at the Global Generics & Biosimilar Awards 2018

We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and...

Read more

09-10-2018

UK generic medicine price flux? – the real data behind the headlines

In 2017, the UK generic medicines market experienced an uncharacteristic amount of volatility creating a number of headlines in the pharmacy trade and mainstream media around the pricing and...

Read more

08-10-2018

Accord UK wins ‘Innovation in the Generics market’ at Pharmacy Business Awards

We were delighted to win the award for ‘Innovation in the Generics market’ at the prestigious Pharmacy Business awards with Methofill®. This award recognises the positive contributions made by...

Read more

04-10-2018

Headline sponsors of the Pharmacy Business Awards

Once again we are the proud headline sponsors of the Pharmacy Business awards in London. In preparation for the awards evening, read what James Burt had to say in his recent ‘Big Interview’...

Read more

28-09-2018

Barnstaple’s first community landing site for Devon Air Ambulance opened at Accord UK

Accord UK officially opened Barnstaple’s first ever community landing site at its Barnstaple factory for Devon Air Ambulance (DAA).

Read more

27-07-2018

Accord Healthcare’s (Intas) Pelgraz® (pegfilgrastim) Given Green Light by CHMP

Pelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe 

Read more

26-07-2018

C & D Awards 2018 Highlights Video

Accord UK were proud to once again headline sponsor the C+D Awards earlier this month.

Read more

Pages